Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

Authors :: Masayuki Imamura
Nobumasa Mizuno
Tetsuhide Ito
Satoshi Hashigaki
Shunsuke Kondo
Toshirou Nishida
Hisato Igarashi
Kazuo Hara
Akira Sawaki
Emiko Ohki
Kenji Yamao
Nobuyuki Kimura
Takuji Okusaka
Mami Murakami
Chigusa Morizane
Richard C. Chao
Source :: Investigational New Drugs. 37:591-591
Publication Year :: 2019
Publisher :: Springer Science and Business Media LLC, 2019.

Subjects :: Pharmacology
Oncology
Pancreatic neuroendocrine tumor
business.industry
Sunitinib
medicine
Cancer research
Phases of clinical research
Pharmacology (medical)
medicine.disease
business
Well differentiated
medicine.drug

Full Text Access

Tools